Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Treatment vs Upfront Surgery for Left Sided Pancreatic Cancer (LEFT-PANC) - a Study Protocol for a Prospective Randomized Multicenter Trial

NCT07155629 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT07155629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Treatment vs Upfront Surgery for Left Sided Pancreatic Cancer (LEFT-PANC) - a Study Protocol for a Prospective Randomized Multicenter Trial
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
August 31, 2030
Enrollment
381 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer resectable